Condition: Crohns Disease · Sponsor: Tr1X, Inc.
This research study is testing an investigational research product called TRX103 as a possible treatment for individuals suffering from Crohn's Disease (CD). The primary purpose of this study is to learn how safe and effective different doses of TRX103 are when administered to individuals with CD.
This description comes directly from the study's public registry record.
Tr1X Clinical Trials Tr1X Clinical Trials · 858-283-7879 · Tr1xClinicalTrials@Tr1x.bio
Study Team · Tr1xClinicalTrials@Tr1x.bio
Always discuss trial participation with your own doctor first.
| Mayo Clinic Arizona | Scottsdale, Arizona, United States | Recruiting |
| University of California, Davis | Sacramento, California, United States | Recruiting |
| University of California, San Francisco | San Francisco, California, United States | Recruiting |
| University of Florida | Gainesville, Florida, United States | Recruiting |
| Northwestern | Chicago, Illinois, United States | Recruiting |
| University of Chicago | Chicago, Illinois, United States | Recruiting |
| University of Iowa | Iowa City, Iowa, United States | Recruiting |
| University of Louisville | Louisville, Kentucky, United States | Recruiting |
| University of Michigan | Ann Arbor, Michigan, United States | Recruiting |
| Mayo Clinic Rochester | Rochester, Minnesota, United States | Recruiting |
| Washington University in St. Louis | St Louis, Missouri, United States | Recruiting |
| Mount Sinai Health Systems | New York, New York, United States | Recruiting |
+ 1 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06721962